Goldman Sachs’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $14.1K | Sell |
|
|||||
|
2022
Q3 | $89K | Sell |
|
|||||
|
2022
Q2 | $147K | Buy |
|
|||||
|
2022
Q1 | $235K | Sell |
|
|||||
|
2021
Q4 | $544K | Buy |
|
|||||
|
2021
Q3 | $716K | Buy |
|
|||||
|
2021
Q2 | $154K | Sell |
|
|||||
|
2021
Q1 | $312K | Buy |
|
|||||
|
2020
Q4 | $165K | Buy |
|
|||||
|
2020
Q3 | $64K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $92K | Sell |
|
|||||
|
2018
Q2 | $162K | Buy |
|
|||||
|
2018
Q1 | $163K | Sell |
|
|||||
|
2017
Q4 | $305K | Buy |
|
|||||
|
2017
Q3 | $99K | Sell |
|
|||||
|
2017
Q2 | $387K | Buy |
|
|||||
|
2017
Q1 | $455K | Sell |
|
|||||
|
2016
Q4 | $288K | Buy |
|
|||||
|
2016
Q3 | $314K | Buy |
|
|||||
|
2016
Q2 | $221K | Sell |
|
|||||
|
2016
Q1 | $8.61M | Sell |
|
|||||
|
2015
Q4 | $23M | Sell |
|
|||||
|
2015
Q3 | $45.5M | Sell |
|
|||||
|
2015
Q2 | $61.2M | Buy |
|
|||||
|
2015
Q1 | $51.5M | Buy |
|
|||||
|
2014
Q4 | $47M | Sell |
|
|||||
|
2014
Q3 | $42.3M | Sell |
|
|||||
|
2014
Q2 | $43.2M | Sell |
|
|||||
|
2014
Q1 | $43.6M | Buy |
|
|||||
|
2013
Q4 | $43.1M | Buy |
|
|||||
|
2013
Q3 | $30.9M | Buy |
|
|||||
|
2013
Q2 | $21M | Buy |
|